For patients with ulcerative colitis, upadacitinib is associated with improved disease-specific outcomes compared with tofacitinib.

Hidradenitis suppurativa is more common among patients with Crohn disease (CD) than ulcerative colitis (UC), yet bowel obstruction affects both CD and UC.

For patients with ulcerative colitis, upadacitinib is associated with improved disease-specific outcomes compared with tofacitinib.

The Crohn’s and Colitis Foundation’s 34th annual Torch Gala is set to take place on Saturday, Feb. 8 in Atlanta, with three ...

Independent women’s singles shuttler Goh Jin Wei bowed out in the first round of the Malaysian Open, but not without showing ...